The mRNA and protein levels of cyclin A2 and cyclin B1 were increased in a tumor compared to normal samples and are promising biomarkers for the diagnosis and prognosis for CRC-suffering patients [52, 55, 56]. This evidence concerns the gene CCNB1 and neoplasm.